» Articles » PMID: 30793054

Vitamin D in Malaria: More Hypotheses Than Clues

Overview
Journal Heliyon
Specialty Social Sciences
Date 2019 Feb 23
PMID 30793054
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Vitamin D is a secosteroid hormone regulating calcium and phosphate metabolism, immune response and brain development. Low blood 25(OH)D levels have been reported in patients affected by infectious diseases caused by parasites, including malaria. Despite the high effectiveness of antimalarials, malaria is burdened with high morbidity and mortality, and the search for additional therapies is rapidly growing. Furthermore, available preventive measures have proved to be barely effective so far. Finding new prevention and therapy tools is a matter of urgency. Studies on animal models and humans have hypothesized some mechanisms by which the hormone can influence malaria pathogenesis, and the role of Vitamin D supplementation in preventing and treating this disease has been suggested. Few studies on the association between Vitamin D and malaria are available and disagreeing results have been reported. Studies in humans reporting an association between low 25(OH)D circulating levels and Malaria have a small sample size and observational study-set. Randomized controlled trials are needed in order to understand if Vitamin D administration might play a role in preventing and treating malaria.

Citing Articles

Vitamin D-Dependent Rickets Type 1A in Two Siblings with a Hypomorphic Variant Frequent in the African Population.

de Brito Chagas J, Cordinha C, do Carmo C, Alves C, Heath K, Sousa S J Pediatr Genet. 2024; 13(1):43-49.

PMID: 38567179 PMC: 10984714. DOI: 10.1055/s-0041-1736559.


Oxidative Stress in Malaria: Potential Benefits of Antioxidant Therapy.

Gomes A, Cunha N, Varela E, Brigido H, Vale V, Dolabela M Int J Mol Sci. 2022; 23(11).

PMID: 35682626 PMC: 9180384. DOI: 10.3390/ijms23115949.


Characterization of Vitamin D Status in Older Persons with Cognitive Impairment.

Arosio B, Rossi P, Ferri E, Cesari M, Vitale G Nutrients. 2022; 14(6).

PMID: 35334800 PMC: 8949190. DOI: 10.3390/nu14061142.


Mendelian randomization study updates the effect of 25-hydroxyvitamin D levels on the risk of multiple sclerosis.

Wang R J Transl Med. 2022; 20(1):3.

PMID: 34980161 PMC: 8722044. DOI: 10.1186/s12967-021-03205-6.


Micronutrient levels and their effects on the prognosis of visceral leishmaniasis treatment, a prospective cohort study.

Feleke B, Feleke T BMC Infect Dis. 2020; 20(1):867.

PMID: 33213392 PMC: 7678206. DOI: 10.1186/s12879-020-05615-1.


References
1.
Kalinec G, Lomberk G, Urrutia R, Kalinec F . Resolution of Cochlear Inflammation: Novel Target for Preventing or Ameliorating Drug-, Noise- and Age-related Hearing Loss. Front Cell Neurosci. 2017; 11:192. PMC: 5500902. DOI: 10.3389/fncel.2017.00192. View

2.
Ray S, Kamath K, Srivastava R, Raghu D, Gollapalli K, Jain R . Serum proteome analysis of vivax malaria: An insight into the disease pathogenesis and host immune response. J Proteomics. 2011; 75(10):3063-80. DOI: 10.1016/j.jprot.2011.10.018. View

3.
Gao Q, Fan Y, Mu L, Ma L, Song Z, Zhang Y . S100B and ADMA in cerebral small vessel disease and cognitive dysfunction. J Neurol Sci. 2015; 354(1-2):27-32. DOI: 10.1016/j.jns.2015.04.031. View

4.
Bivona G, Agnello L, Ciaccio M . Vitamin D and Immunomodulation: Is It Time to Change the Reference Values?. Ann Clin Lab Sci. 2017; 47(4):508-510. View

5.
Daley P, Jagannathan V, John K, Sarojini J, Latha A, Vieth R . Adjunctive vitamin D for treatment of active tuberculosis in India: a randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2015; 15(5):528-34. DOI: 10.1016/S1473-3099(15)70053-8. View